Clinical Trial Update: Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating KW-3902IV in combination with intravenous furosemide for improving renal function in patients with congestive heart failure and renal i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Insufficiency

Drugs mentioned

• FUROSEMIDE (Furosemide)
• KW-3902IV

Snippet

Sponsor: NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Heart Failure, Congestive, Renal Insufficiency | Phase 2 | Status: COMPLETED